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Recently it has been suggested [(1987) Nature 325,45&458; (1987) FEBS Lett. 212, 123-1261 that the activa- 
tion of Na+/H+ exchange is a prerequisite for platelet aggregation and the development of the Ca2+ signal. 
As direct evidence for the role of the Na+/H+-exchange pathway the inhibition of the Ca2+ signal by EIPA, 
a specific inhibitor of Na+/H+ exchange, was offered. Here we demonstrate that low concentrations of 
EIPA (below 1 PM) completely block Na+/H+ exchange while EIPA inhibits aggregation or Ca2+ mobiliza- 
tion only in concentrations lOO-times greater than 1 ,uM. Moreover, another amiloride analogue, CBDMB, 
developed to act predominantly on Na+/Ca2+ exchange, does not affect Na+ /H + exchange in platelets but 
blocks aggregation and Ca2+ mobilization. We conclude that while Na+/H+ exchange has a fundamental 
role in platelet functions it is not prerequisite for the development of Ca2+ signal and aggregation. 
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1. INTRODUCTION 
By now it is generally accepted that cell activa- 
tion by a variety of stimulating agents is mediated 
by a rapid rise in [Ca2+]i and involves the specific 
hydrolysis of phosphatidylinositol 4,5-bisphos- 
phate to yield InsP3 and DAG. InsP3 liberates 
Ca2+ from a non-mitochondrial intracellular store 
while DAG may act through the activation of pro- 
tein kinase C which, in turn, can activate Na+/H+ 
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exchange in the plasma membrane [3-71. The ac- 
tual timing of all these intracellular events is still 
poorly understood and platelets provide a relative- 
ly well manageable model system for studying 
these phenomena. Several studies in platelets have 
indicated that a thrombin-induced Ca2+ signal 
precedes the activation of Na+/H+ exchange 
[8-lo]. However, in their recent communications 
Siffert et al. [1,2] concluded that the activation of 
sodium-proton exchange is a prerequisite for Ca2+ 
mobilization and aggregation in human platelets. 
They showed that removal of external Na+ strong- 
ly reduced the thrombin-induced increase in 
[Ca2+]i as measured in quin2-loaded platelets, both 
in the presence or absence of external Ca2+. An 
amiloride analogue, EIPA, inhibitor of the 
Nat/H+-exchange transport, also inhibited this 
Ca2+ signal, while the resting [Ca2+]i was unchang- 
ed. The authors further showed that removal of 
Na+ inhibited H’ extrusion, while intracellular 
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alkalinization potentiated the thrombin-induced 
Ca*+ signal and platelet aggregation. Moreover, 
thrombin induced an intracellular alkaline shift 
and this was prevented by the removal of external 
Na+ or by the addition of EIPA. 
The only direct evidence for the role of the 
Na+/H+-exchange pathway in Ca*+ mobilization 
is the inhibition of the Ca*+ signal by EIPA in 
quin2-loaded platelets. However, in these ex- 
periments [1,2] the authors used 40-100 ,xM of this 
inhibitor, while the half-maximal inhibitory con- 
centration of EIPA on Na+/H+ exchange, as 
measured in a variety of tissues at physiological 
Na+ concentrations, is about 0.1 FM [ 1 l-141. 
Thus a non-specific effect of this amiloride 
analogue in these high concentrations may occur. 
In order to resolve these questions we have 
measured the concentration-dependent effects of 
EIPA and another amiloride analogue, CBDMB, 
on Ca*+ mobilization, aggregation and on 
Na+/H+ exchange as reflected by a Na- 
propionate-induced swelling in human platelets. 
The amiloride analogue CBDMB was developed to 
act predominantly on Na+/Ca*+ exchange, 
because as a consequence of substitution of the 
guanidino group of amiloride it has a negligible ef- 
fect on Na+/H+ exchange (Ki above 500pM) 
[13-151, while its Ki for Na+/Ca*+ exchange is 
7.3 PM as demonstrated on pituitary plasma mem- 
brane vesicles using the method described in [16] 
(Kaczorowski, G. J., personal communication). 
2. MATERIALS AND METHODS 
Platelets were isolated from freshly drawn 
titrated blood by centrifugation at 400 x g for 
10 min. Platelet-rich plasma was centrifuged for 
15 min at 1200 x g and the platelets were 
resuspended in a nominally Ca*+-free Tyrode solu- 
tion (pH 7.25). Platelets were loaded with quin2 by 
incubating them in the same solution containing 
15 PM quin2-acetoxymethyl ester (Calbiochem) 
for at least 30 min at room temperature. Then the 
cells were centrifuged for 10 s at 10000 x g, rinsed 
twice and resuspended (lo8 cells/ml) in the same 
solution. Fluorescence was measured by a Hitachi 
F-4000 fluorescent spectrophotometer at 37°C 
with continuous stirring. Fluorescence was record- 
ed at an excitation wavelength of 337 nm (5 nm 
slit) and an emission wavelength of 490 nm (5 nm 
slit). Calibration of [Ca*+]i was carried out as 
described in [17,18] using an apparent Kd of 
115 nM for Ca*+-quin2 (cf. [17]). CBDMB gave a 
concentration-dependent background fluorescence 
independent of divalent cations or thrombin and 
this fluorescence has been subtracted. Aggregation 
was measured in the same quinZloaded cells in the 
presence of 1% plasma in a Lumi-aggregometer 
(Chrono-log, model 460, PICA), at 37°C. EIPA, 
DMB and CBDMB were synthesised by the 
methods described [ 19,201. 
For measuring Nat/H+ exchange quin2-loaded 
or control platelets were suspended at 0 min in a 
Na-propionate medium (140 mM Na-propionate, 
1 mM CaCl2, 2 mM MgC12, 5.5 mM glucose, 
20 mM Tris-HCl, pH 6.8). Cell volume was 
measured by an electronic sizing (Coulter-type) in- 
strument (Laborscale, Medicor). Cell volume was 
calibrated by latex beads. There was no difference 
observed in this experiment between control or 
quin2-loaded platelets. 
3. RESULTS AND DISCUSSION 
3.1. Effects of EIPA and CBDMB on Cd’ signal 
and aggregation 
Fig.1 demonstrates the effects of EIPA and 
CBDMB on the thrombin-induced increase in 
[Ca2+]i in quin2-loaded human platelets. Up to 
10 FM concentration EIPA has no effect on ag- 
gregation or on the Ca2+ signal. It was previously 
reported by Siffert et al. (211 and others [lo] that 
EIPA at this concentration (10pM) almost com- 
pletely abolishes thrombin-induced alkalinization. 
As shown in fig. 1, 10 PM CBDMB or 40 PM EIPA 
inhibit the Ca*+ signal and aggregation. By a 
detailed analysis of these effects we found that 
half-maximum inhibition was obtained by about 
30 ,xM EIPA and 3-5 PM CBDMB. Both EIPA 
and CBDMB had the above concentration- 
dependent effects on the thrombin-induced rise of 
[Ca*+]i n quin2-loaded platelets in the absence of 
external Ca*+ as well (not shown). It has to be 
mentioned that 10 PM CBDMB, in the presence of 
1 mM external Ca*+, produced a slow rise in 
platelet [Ca*+]i (fig. 1). This effect was independent 
of the addition of thrombin (not shown) and 
caused a delayed, non-specific, slow aggregation. 
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Fig. 1. Effects of EIPA and CBDMB on the thrombin-induced increase in [Caz’]i (upper panel) and aggregation (lower 
panel) in human platelets loaded with the fluorescent Ca’+ indicator quin2. (A) Control; (B) 10 pM EIPA; (C) 40 PM 
EIPA; (D) 10pM CBDMB. The arrows indicate the addition of CaClz (final cont. 1 mM) and thrombin (0.5 U/ml). 
Each trace represents experiments repeated with three or four different preparations. 
3.2. Effects of EIPA and CBDMB on Na+/H+ 
exchange 
Fig.2 shows the effects of EIPA and CBDMB on 
Na+/H+ exchange in human platelets. It was 
studied by using a simple test-system: swelling in a 
Na-propionate medium. This method has been 
used in various cell types to follow the functioning 
of the Na+/H+-exchange system [22-251 as in a 
Na-propionate medium undissociated propionic 
40~hl EIPA 10pM CBDMB 
acid enters the cells and cytoplasmic acidification 
initiates Na+/H+ exchange. These processes result 
in net Na+ and propionate entry and cell swelling. 
The increase in cell volume can be followed by 
electronic sizing and any inhibitor of Na+/H+ ex- 
change stops this swelling [23-251. This swelling 
can only occur if a coupled Na+/H+ exchange is in 
operation and, as shown in fig.2, is strongly in- 
hibited by low concentrations of EIPA. Based on 
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gregation and Ca2+ mobilization, thus the 
activation of Na+/H+ exchange is not a prere- 
quisite for these processes. The modulating effects 
of external Na+ and the inhibition of platelet ac- 
tivation by amiloride derivatives may indicate a 
certain role for Na+/Ca2+ exchange or other, as 
yet unidentified Na+-dependent processes. 
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Fig.2. Effects of EIPA and CBDMB on Na+/H+ 
exchange as measured by platelet swelling in a Na- 
propionate medium. Results are representative of four 
independent experiments. (A) Control; (B) 1OpM 
CBDMB; (C) 0.1 PM EIPA; (D) 2 ,uM EIPA; (E) 10 PM 
EIPA. 
four different experiments the half-maximal in- 
hibition was obtained between 0.1 and 0.2 PM 
EIPA, in good agreement with the data for the in- 
hibition of Na+/H+ exchange by EIPA in other 
tissues [l l-141. CBDMB was found to be ineffec- 
tive on Na+/H+ exchange-dependent platelet 
swelling up to the concentration of 10 FM (higher 
concentrations produced platelet degradation). 
Another amiloride analogue, DMB, specific for 
inhibition of Na+/Ca’+ exchange in different 
tissues [16] acted similarly to CBDMB (not 
shown). 
4. CONCLUSIONS 
From the above experimental findings we con- 
clude that EIPA inhibits Ca2+ mobilization and ag- 
gregation of human platelets only in 
concentrations more than lOO-times greater than 
that required to block Na+/H+ exchange. In con- 
trast the amiloride analogue CBDMB, presumed to 
act dominantly on Na+/Ca2+ exchange, inhibits 
the signal and aggregation without any effect on 
the Na+/H+-exchange system. Certainly, the in- 
hibition of Na+/H+ exchange does not prevent ag- 
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